Skip to main content
. 2020 Dec 1;23(12):775–782. doi: 10.1093/ijnp/pyaa006

Table 1.

Baseline Characteristics of the Patients

Variable Reseveratrol (n = 26) Placebo (n = 26)
Gender, F(%) 10 (38%) 11 (42%)
Age, mean ± SD 34.73 ± 7.03 33.08 ± 5.48
Duration of illness, y, mean ± SD 11.46 ± 6.43 10.65 ± 5.20
Schizophrenia subtype
 Paranoid(%) 16 (61%) 17 (69%)
 Residual(%) 4 (15%) 5 (19%)
 Undifferentiated(%) 6 (23%) 5 (19%)
Marital status Single: 16 (61%) Single: 18 (69%)
Married: 7 (27%), Married: 5 (19%),
Divorced: 3 (11%) Divorced: 3 (11%)
Level of education Less than high school
diploma: 19 (73%),
diploma: 4 (15%),
illiterate: 3 (11%)
Less than high school
diploma: 17 (69%),
diploma: 7 (27%),
illiterate 2 (7%)
Smoking 22 (84%) 23 (88%)
Baseline HDRS score, mean ± SD 9.84 ± 1.97 10.15 ± 1.97
Baseline ESRS, mean ± SD 0.77 ± 0.99 0.38 ± 0.70
Baseline PANSS
 Total score 70.08 ± 5.11 70.27 ± 4.21
 Negative symptoms 17.69 ± 2.53 18.04 ± 1.75
 Positive symptoms 20.58 ± 1.90 20.31 ± 2.17
 General psychopathology 31.81 ± 2.40 31.92 ± 1.74

Abbreviations: ESRS, extrapyramidal symptom rating scale; F, female; HDRS, Hamilton Depression Rating Scale; PANSS, positive and negative syndrome scale.